InMed Pharmaceuticals Inc. (INM): Shareholders' Equity
$1.08M
As of 2026-06-30
-55.4%
3-year compound annual growth
-32.0%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $1.08M | -92.0% | 2026-09-09, Balance as of period end |
| 2025-06-30 | $13.43M | +45.9% | 2026-09-09, Balance as of period end |
| 2024-06-30 | $9.21M | -23.9% | 2025-09-23, Balance as of period end |
| 2023-06-30 | $12.09M | +33.2% | 2024-09-30, Balance as of period end |
| 2022-06-30 | $9.08M | +23.1% | 2023-09-29, Balance as of period end |
| 2021-06-30 | $7.38M | +25.5% | 2022-09-23, Balance as of period end |
| 2020-06-30 | $5.88M | n/a | 2021-09-24, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | 2026-06-30 | $1.08M | -92.0% |
| Hepion Pharmaceuticals, Inc. (HEPA) | 2025-12-31 | $2.67M | n/m |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | $2.15M | +4.4% |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | $1.83M | -34.5% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | -$17.51M | n/m |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.14M | -57.0% |
| Artelo Biosciences, Inc. (ARTL) | 2025-12-31 | -$1.27M | n/m |
| Protagenic Therapeutics, Inc.\new (PTIX) | 2026-03-31 | $2.62M | n/m |
| Inhibitor Therapeutics, Inc. (INTI) | 2025-12-31 | -$1.29M | n/m |
Compare INM, HEPA, TCRT, ATXI side by side · Screen every company in Pharmaceutical Preparations ↗